| Delta Podiatry Group, Inc. | |
|
1205 N Hunter St, Stockton, CA 95202-1409 | |
| (209) 464-7367 | |
| (209) 464-1801 |
| Full Name | Delta Podiatry Group, Inc. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 1205 N Hunter St, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023169471 | NPI | - | NPPES |
| E1406 | Other | CA | LICENSE NUMBER |
| ZZZ73253Z | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E1406 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Delta Podiatry Group, Inc. 1205 N Hunter St, Stockton, CA 95202-1409 Ph: (209) 464-7367 | Delta Podiatry Group, Inc. 1205 N Hunter St, Stockton, CA 95202-1409 Ph: (209) 464-7367 |
News Archive
A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers.
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from patients with type 1 diabetes.
People are continuously exposed to a huge amount and variety of potentially toxic chemicals present in the surrounding environment, such as pesticides or drugs traces in water, soil, air and living organisms. The combined action of pollutants can increase the risk of toxic effects.
The National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) has awarded a two-year grant to the Medical Technology and Practice Patterns Institute (MTPPI) in collaboration with Harvard School of Public Health (HSPH) to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy.
Postmenopausal women with osteoporosis who take denosumab long-term have increased bone density, sustained low rate of fractures, and a favorable benefit/risk profile, a new multinational study finds.
› Verified 4 days ago
Craig Anthony Lenz, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1755 W Hammer Ln Ste 7b, Stockton, CA 95209 Phone: 909-599-0891 Fax: 909-592-0738 | |
Igal Palma, Podiatrist Medicare: Medicare Enrolled Practice Location: 221 E 8th St, Stockton, CA 95206 Phone: 213-718-4901 | |
Kenneth K Shimozaki, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3031 W March Ln, Suite 310, Stockton, CA 95219 Phone: 209-472-0800 Fax: 209-472-1203 | |
Darrell G Paul, Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
Dr. Rabeea Khan, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3031 W March Ln Ste 310, Stockton, CA 95219 Phone: 209-472-0800 Fax: 209-472-1203 | |
Seiha Thorng, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 420 W Acacia St Ste 18, Stockton, CA 95203 Phone: 209-425-4846 Fax: 209-425-0570 |